Her-2: The Making Of Herceptin, A Revolutionary Treatment For Breast Cancer-..
-
- 1x de R$ 157,70 sem juros
- 2x de R$ 78,85 sem juros
- 3x de R$ 52,56 sem juros
-
R$ 149,82
-
R$ 157,70
Two years after she underwent a mastectomy and chemotherapy, Barbara Bradfield's aggressive breast cancer had recurred and spread to her lungs. The outlook was grim. Then she took part in Genentech's clinical trials for a new drug. Five years later she remains cancer-free. Her-2 is the biography of Herceptin, the drug that provoked dramatic responses in Barbara Bradfield and other women in the trials and that offers promise for hundreds of thousands of breast cancer patients. Unlike chemotherapy or radiation, Herceptin has no disabling side effects. It works by inactivating Her-2/neu--a protein that makes cancer cells grow especially quickly-- produced by a gene found in 25 to 30 percent of all breast tumors. Herceptin caused some patients' cancers to disappear completely; in others, it slowed the progression of the disease and gave the women months or years they wouldn't otherwise have had. Herceptin is the first treatment targeted at a gene defect that gives rise to cancer. It marks the beginning of a new era of treatment for all kinds of cancers. Robert Bazell presents a riveting account of how Herceptin was born. Her-2 is a story of dramatic discoveries and strong personalities, showing the combination of scientific investigation, money, politics, ego, corporate decisions, patient activism, and luck involved in moving this groundbreaking drug from the lab to a patient's bedside. Bazell's deft portraits introduce us to the remarkable people instrumental in Herceptin's history, including Dr. Dennis Slamon, the driven UCLA oncologist who played the primary role in developing the treatment; Lily Tartikoff, wife of television executive Brandon Tartikoff, who tapped into Hollywood money and glamour to help fund Slamon's research; and Marti Nelson, who inspired the activists who lobbied for a "compassionate use" program that would allow women outside the clinical trials to have access to the limited supplies of Herceptin prior to FDA approval of the drug. And throughout there are the stories of the heroic women with advanced breast cancer who volunteered for the trials, risking what time they had left on an unproven treatment. Meticulously researched, written with clarity and compassion, Her-2 is masterly reporting on cutting-edge science.
| ISBN | 9780812991840 |
| Autor(a) | Bazell, Robert |
| Editora | Random House |
| Ano de edição | 1998 |
| Acabamento | Brochura |
Produtos relacionados
-
The Twentysomething Treatment: A Revolutionary Remedy For An Uncertain Age-..R$ 240,62até 4x de R$ 60,15 sem jurosou R$ 228,59 via Pix -
The Twentysomething Treatment: A Revolutionary Remedy For An Uncertain Age-..R$ 157,62até 3x de R$ 52,54 sem jurosou R$ 149,74 via Pix
-
How To Prevent Breast Cancer--before & After: A Guide To Taking Back Control Of Your Life-..R$ 157,29até 3x de R$ 52,43 sem jurosou R$ 149,43 via Pix
Categorias
Conteúdo
Sobre a loja
Myre Livraria, sua livraria online especializada em importação e revenda de livros nacionais e internacionais. Oferecemos uma vasta seleção de materiais didáticos de alta qualidade para aprender inglês, espanhol, francês, alemão e muito mais. Aproveite preços competitivos e entrega rápida em todo o Brasil
Pague com
Selos
Myre Editora Ltda. - CNPJ: 50.295.718/0001-20 © Todos os direitos reservados. 2025
